Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis
Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin